Drug Database
Back to search

Japan· JP-3969011F1055

ビルダグリプチン

A vildagliptin product containing ビルダグリプチン, registered in Japan by 全星薬品工業, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

On Japan’s NHI price listATC A10BH02

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedビルダグリプチンATCA10BH02REGISTER NO.JP-3969011F1055PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ビルダグリプチンAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Vildagliptin is registered in 16 of 19 countries.

Countries holding a registration under ATC A10BH02 (vildagliptin), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 9 of them publish a price we can compare per daily dose
Search vildagliptin products by name

Vildagliptin · ATC A10BH02

16 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of vildagliptin costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), the median price runs from $0.32 in France to $1.98 in Switzerland — a ×6.2 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Vildagliptin · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.98
  • IT Italy$1.0
  • FR France$0.32
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

MHLW / PMDA (Japan)
Active substance
ビルダグリプチン
Manufacturer
全星薬品工業
Country
Japan (JP)
ATC code
A10BH02
ATC class
Vildagliptin
Defined daily dose
0.1 g, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under A10BH02

Vildagliptin, as other registers publish it.

All vildagliptin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e4235bb8-47b4-44bd-810a-dfd3fa9a51ce
GET /v1/drugs/e4235bb8-47b4-44bd-810a-dfd3fa9a51ce?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "５０ｍｇ１錠",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "3969011F1055",
  "category": "内用薬",
  "price_yen": 16,
  "generic_name": "ビルダグリプチン",
  "product_name_jp": null,
  "therapeutic_class": "3969",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about vildagliptin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console